Filing Flows

Filing Flows › 8-K events › CapForce

CapForce: departure or appointment of directors and officers

Form 8-K filed Nov 6, 2026 · items 5.02, 5.03

What the filing says

On October 27, 2026, the Board of Directors (the “Board”) of CapForce Inc. (the “Company”) approved certain changes to the management of the Company and the Board. In connection with these changes, the Board re-assigned Christian-Laurent Benoit Bonte from his position as Chief Executive Officer of the Company to the Pr

Read the filing on SEC EDGAR →

What usually followsAcross 39,174 8-Ks reporting Item 5.02 (directors and officers: departures, appointments, pay) in our universe, the stock's median move the next session was −0.1% (typical size ±1.4%, up 48% of the time); over the following 21 sessions, +0.7%. Item 5.03: +0.1% next session across 5,869. Every item ranked →

What this kind of filing means

Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.

CapForce at a glance

Latest quarterQ2 2026
Revenue$50.0M
Revenue Y/Y12×
Operating margin88.6%
IndustryServices-Medical Laboratories

CapForce, Q2 2026: revenue $50.0M (12× year over year), operating margin 88.6%. The chart follows the revenue to costs, profit and cash.

CapForce: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent ceo changes

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.